NEURODIVERGENT BIRTH CIC

Company limited by guarantee

Company Registration Number:
SC797562 (Scotland)

Unaudited statutory accounts for the year ended 28 February 2025

Period of accounts

Start date: 2 February 2024

End date: 28 February 2025

NEURODIVERGENT BIRTH CIC

Contents of the Financial Statements

for the Period Ended 28 February 2025

Directors report
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

NEURODIVERGENT BIRTH CIC

Directors' report period ended 28 February 2025

The directors present their report with the financial statements of the company for the period ended 28 February 2025

Principal activities of the company

The principal activity of the company continued to be that of neurodivergent support for pregnancy, birth, and beyond.



Directors

The directors shown below have held office during the whole of the period from
2 February 2024 to 28 February 2025

Victoria White
Louise Dredge
Grace Williams


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
31 October 2025

And signed on behalf of the board by:
Name: Victoria White
Status: Director

NEURODIVERGENT BIRTH CIC

Balance sheet

As at 28 February 2025

Notes 13 months to 28 February 2025


£
Fixed assets
Tangible assets: 3 16,482
Total fixed assets: 16,482
Current assets
Debtors: 4 97
Cash at bank and in hand: 2,613
Total current assets: 2,710
Creditors: amounts falling due within one year: 5 ( 23,265 )
Net current assets (liabilities): (20,555)
Total assets less current liabilities: (4,073)
Total net assets (liabilities): (4,073)
Members' funds
Profit and loss account: (4,073)
Total members' funds: ( 4,073)

The notes form part of these financial statements

NEURODIVERGENT BIRTH CIC

Balance sheet statements

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 31 October 2025
and signed on behalf of the board by:

Name: Victoria White
Status: Director

The notes form part of these financial statements

NEURODIVERGENT BIRTH CIC

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Tangible fixed assets depreciation policy

    Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases: Fixtures and fittings 20% reducing balance Computers 33% straight line Motor vehicles 20% reducing balance The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to surplus or deficit.

    Other accounting policies

    1.4 Impairment of fixed assets At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs. Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in surplus or deficit, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease. Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cashgenerating unit) in prior years. A reversal of an impairment loss is recognised immediately in surplus or deficit, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase. 1.6 Financial instruments The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Classification of financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Basic financial liabilities Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method. 1.7 Taxation The company is exempt from corporation tax, it being a company not carrying on a business for the purposes of making a profit. 1.8 Employee benefits The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets. The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received. Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits. 1.9 Leases Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed. 1.10 Government grants Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

NEURODIVERGENT BIRTH CIC

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 2. Employees

    13 months to 28 February 2025
    Average number of employees during the period 1

NEURODIVERGENT BIRTH CIC

Notes to the Financial Statements

for the Period Ended 28 February 2025

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
Additions 20,990 20,990
Disposals
Revaluations
Transfers
At 28 February 2025 20,990 20,990
Depreciation
Charge for year 4,508 4,508
On disposals
Other adjustments
At 28 February 2025 4,508 4,508
Net book value
At 28 February 2025 16,482 16,482

NEURODIVERGENT BIRTH CIC

Notes to the Financial Statements

for the Period Ended 28 February 2025

4. Debtors

13 months to 28 February 2025
£
Other debtors 97
Total 97

NEURODIVERGENT BIRTH CIC

Notes to the Financial Statements

for the Period Ended 28 February 2025

5. Creditors: amounts falling due within one year note

13 months to 28 February 2025
£
Other creditors 23,265
Total 23,265

COMMUNITY INTEREST ANNUAL REPORT

NEURODIVERGENT BIRTH CIC

Company Number: SC797562 (Scotland)

Year Ending: 28 February 2025

Company activities and impact

During this financial year, Neurodivergent Birth CIC has continued its work to improve experiences and outcomes for neurodivergent people in the perinatal period - through education, advocacy, and the creation of inclusive, evidence-based resources. Our activities have included the delivery of professional training for perinatal practitioners and healthcare professionals, focusing on understanding and supporting autistic, ADHD and otherwise neurodivergent people through pregnancy, birth, and the postnatal period. We have also supported neurodivergent expectant and new parents through the Neurodivergent Birth Preparation Course and the Neurodivergent Birth Podcast, which has now reached over 12,000 downloads and continues to grow as an accessible, community-centred educational resource. We have produced free public resources in collaboration with partners such as PANDAS Foundation UK and White Ribbon Alliance UK, helping to raise awareness of inequities faced by neurodivergent parents and improve accessibility in perinatal mental health and reproductive healthcare. Our work this year has directly benefited the neurodivergent community by: Increasing access to neuroaffirming information and practical tools for pregnancy and postnatal wellbeing. Supporting healthcare and birth professionals to develop inclusive, compassionate practice. Creating community connections that reduce isolation and validate lived experience. Through our training, advocacy and collaboration, Neurodivergent Birth CIC continues to challenge systemic barriers and promote a culture of inclusion, respect and empowerment for all birthing people and families.

Consultation with stakeholders

The stakeholders of Neurodivergent Birth CIC include: - Neurodivergent expectant and new parents who use our educational and community resources. - Perinatal and maternity care professionals, including midwives, doulas, health visitors, and mental health practitioners who access our training. - Partner organisations and charities such as PANDAS Foundation UK, White Ribbon Alliance UK, Make Birth Better CIC and the Maternity Autism Research Group (MARG). - Members of the Neurodivergent Birth practitioner network, who collaborate on training delivery and peer support. Throughout the year, stakeholder consultation has taken place through a variety of methods including: - Post-training feedback forms and reflective sessions, allowing participants to share insights and suggest improvements. - Informal community consultations via social media, online discussion spaces, and direct messages from neurodivergent parents and practitioners. - Collaborative partnerships and co-production meetings with external organisations and researchers, ensuring our work remains evidence-based and representative of community needs. - Podcast listener feedback and topic suggestions, which inform ongoing content creation and community engagement. In response to stakeholder feedback, the CIC has: - Developed new training modules and accessible resources, particularly around sensory needs, communication, and trauma-informed practice. - Ensured that all materials use inclusive language, respecting gender diversity and diverse feeding choices (e.g. breastfeeding and chestfeeding). - Strengthened collaborative relationships with charities and academic partners to ensure resources are accurate, accessible, and impactful. - Planned future expansion of peer support opportunities for neurodivergent parents and professionals, in response to requests for greater community connection. Through continuous consultation and co-production with our stakeholders, Neurodivergent Birth CIC ensures that our work remains grounded in lived experience, inclusive practice, and community empowerment.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
31 October 2025

And signed on behalf of the board by:
Name: Vicoria White
Status: Director